Regular updates related to sourcing and the management of health products are available on this page.
-
09 February 2021
Global Fund Finalizes Procurement Service Agent Fees
-
22 January 2021
Update for PRs on Placing Orders and Procuring COVID-19 Products in 2021
-
30 November 2020
COVID-19 Response: Scaling-Up Testing with Antigen-Detection Diagnostics
-
18 September 2020
COVID-19 Response: Procurement of Automated Polymerase Chain Reaction Diagnostic Tests
The Global Fund is working with partners to rapidly and equitably support access to COVID-19 health products and diagnostics for low- and middle-income countries by following the World Health Organization’s allocation model. -
15 September 2020
COVID-19 Response: Antigen-Detection Diagnostic Test Procurement
Following the World Health Organization’s interim guidance on antigen-detection in the diagnosis of COVID-19 from 11 September, the Global Fund anticipates being able to support countries in accessing high-performing antigen-detecting rapid diagnost... -
08 September 2020
COVID-19 Response: Corticosteroids Procurement
Following the World Health Organization guidance Corticosteroids for COVID-19 from 2 September, the Global Fund has confirmed that corticosteroids can be funded through Global Fund grants.